CHRISTOPHER M PIECZONKA M.D.
Prescription History 1376530121
Urology in Syracuse, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHRISTOPHER M PIECZONKA M.D., an active Urology specialist practicing in Syracuse, NY. Our medical registry currently tracks 26 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,758 documented patient claims. Among these therapy options, the most frequently utilized medication is Orgovyx, which accounts for 486 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| OrgovyxRelugolix | 486 | $2,970.88 | ▲ More than typical |
About Orgovyx: Relugolix is used to treat prostate cancer in men. Show more ▾ It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Relugolix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells. In 2023, this provider wrote 486 Medicare prescriptions for Orgovyx, about 12 times the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $2,970.88 per fill, versus $2,629.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 488 30-Day Fills standardized to 30-day supplies 14,636 Days of Medication total across all patients in 2023 | |||
| Tamsulosin Hcl | 282 | $24.62 | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 282 Medicare prescriptions for Tamsulosin Hcl, about 3.1 times the volume of the typical New York prescriber of this medication (92). Medicare paid an average of $24.62 per fill, versus $19.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 765.5 30-Day Fills standardized to 30-day supplies 22,939 Days of Medication total across all patients in 2023 | |||
| NubeqaDarolutamide | 271 | $13,587.02 | ▲ More than typical |
About Nubeqa: Darolutamide is used to treat a certain type of prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 271 Medicare prescriptions for Nubeqa, about 8.5 times the volume of the typical New York prescriber of this medication (32). Medicare paid an average of $13,587.02 per fill, versus $12,476.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 275 30-Day Fills standardized to 30-day supplies 8,235 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 199 | $3,260.37▼ below NY avg | ▲ More than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 199 Medicare prescriptions for Abiraterone Acetate, about 4.5 times the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $3,260.37 per fill, versus $3,990.89 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 211 30-Day Fills standardized to 30-day supplies 6,330 Days of Medication total across all patients in 2023 | |||
| ErleadaApalutamide | 189 | $14,962.34 | ▲ More than typical |
About Erleada: Apalutamide is used to treat men with prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 189 Medicare prescriptions for Erleada, about 8.2 times the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $14,962.34 per fill, versus $13,992.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 191 30-Day Fills standardized to 30-day supplies 5,730 Days of Medication total across all patients in 2023 | |||
| Finasteride | 183 | $20.44 | ▲ More than typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2023, this provider wrote 183 Medicare prescriptions for Finasteride, about 3 times the volume of the typical New York prescriber of this medication (62). Medicare paid an average of $20.44 per fill, versus $15.53 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 512 30-Day Fills standardized to 30-day supplies 15,360 Days of Medication total across all patients in 2023 | |||
| Prednisone | 177 | $8.04 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 177 Medicare prescriptions for Prednisone, about 4 times the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $8.04 per fill, versus $6.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 257 30-Day Fills standardized to 30-day supplies 7,681 Days of Medication total across all patients in 2023 | |||
| Dutasteride | 163 | $52.40 | ▲ More than typical |
About Dutasteride: This medication is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It works by reducing the size of the enlarged prostate. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). It may also reduce the need for surgery to treat BPH. Dutasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. This medication should not be used by women or children. A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA. In 2023, this provider wrote 163 Medicare prescriptions for Dutasteride, about 4.1 times the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $52.40 per fill, versus $51.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 423.6 30-Day Fills standardized to 30-day supplies 12,707 Days of Medication total across all patients in 2023 | |||
| XtandiEnzalutamide | 151 | $14,574.32 | ▲ More than typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 151 Medicare prescriptions for Xtandi, about 4.9 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $14,574.32 per fill, versus $13,202.61 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 153 30-Day Fills standardized to 30-day supplies 4,590 Days of Medication total across all patients in 2023 | |||
| Silodosin | 110 | $112.39▼ below NY avg | ▲ More than typical |
About Silodosin: Silodosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Silodosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 110 Medicare prescriptions for Silodosin, about 2.8 times the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $112.39 per fill, versus $131.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 246 30-Day Fills standardized to 30-day supplies 7,380 Days of Medication total across all patients in 2023 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 100 | $29.64 | ▲ More than typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 100 Medicare prescriptions for Alfuzosin Hcl Er, about 1.8 times the volume of the typical New York prescriber of this medication (56). Medicare paid an average of $29.64 per fill, versus $26.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 237.3 30-Day Fills standardized to 30-day supplies 7,100 Days of Medication total across all patients in 2023 | |||
| GemtesaVibegron | 80 | $1,044.54 | ▲ More than typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. In 2023, this provider wrote 80 Medicare prescriptions for Gemtesa, about 1.5 times the volume of the typical New York prescriber of this medication (53). Medicare paid an average of $1,044.54 per fill, versus $636.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 179.4 30-Day Fills standardized to 30-day supplies 5,330 Days of Medication total across all patients in 2023 | |||
| YonsaAbiraterone Acet,submicronized | 61 | $9,830.46 | ≈ Typical |
About Yonsa: This medication is used to treat men with prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, which helps slow down the growth and spread of prostate cancer. This medication should not be used by women or children. In 2023, this provider wrote 61 Medicare prescriptions for Yonsa, about the same volume as the typical New York prescriber of this medication (64). Medicare paid an average of $9,830.46 per fill, versus $8,917.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 46 | $1,291.38 | ≈ Typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 46 Medicare prescriptions for Myrbetriq, about 82% of the volume of the typical New York prescriber of this medication (56). Medicare paid an average of $1,291.38 per fill, versus $638.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 136 30-Day Fills standardized to 30-day supplies 4,080 Days of Medication total across all patients in 2023 | |||
| Tadalafil | 41 | $240.38▼ below NY avg | ≈ Typical |
About Tadalafil: Tadalafil is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. In 2023, this provider wrote 41 Medicare prescriptions for Tadalafil, about 1.2 times the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $240.38 per fill, versus $576.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 85 30-Day Fills standardized to 30-day supplies 2,530 Days of Medication total across all patients in 2023 | |||
| Methylprednisolone | 40 | $17.65 | ≈ Typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2023, this provider wrote 40 Medicare prescriptions for Methylprednisolone, about 1.3 times the volume of the typical New York prescriber of this medication (32). Medicare paid an average of $17.65 per fill, versus $11.18 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 36 | $16.76▼ below NY avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 36 Medicare prescriptions for Gabapentin, about half the volume of the typical New York prescriber of this medication (78). Medicare paid an average of $16.76 per fill, versus $17.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,500 Days of Medication total across all patients in 2023 | |||
| Potassium Citrate ErPotassium Citrate | 25 | $148.07 | ≈ Typical |
About Potassium Citrate Er: This medication is used to make the urine less acidic. Show more ▾ This effect helps the kidneys get rid of uric acid, thereby helping to prevent gout and kidney stones. This medication can also prevent and treat certain metabolic problems (acidosis) caused by kidney disease. Citric acid and citrate salts (which contain potassium and sodium) belong to a class of drugs known as urinary alkalinizers. If you have a condition that requires you to limit your intake of potassium and sodium, your doctor may direct you to take a product that is lower in potassium and sodium. A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher. In 2023, this provider wrote 25 Medicare prescriptions for Potassium Citrate Er, about 76% of the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $148.07 per fill, versus $138.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 1,290 Days of Medication total across all patients in 2023 | |||
| Ciprofloxacin Hcl | 21 | $4.85▼ below NY avg | ▼ Less than typical |
About Ciprofloxacin Hcl: This medication is used to treat eye infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2023, this provider wrote 21 Medicare prescriptions for Ciprofloxacin Hcl, about 72% of the volume of the typical New York prescriber of this medication (29). Medicare paid an average of $4.85 per fill, versus $7.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21 30-Day Fills standardized to 30-day supplies 180 Days of Medication total across all patients in 2023 | |||
| Potassium Chloride | 20 | $17.57▼ below NY avg | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2023, this provider wrote 20 Medicare prescriptions for Potassium Chloride, about half the volume of the typical New York prescriber of this medication (46). Medicare paid an average of $17.57 per fill, versus $32.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| Darifenacin ErDarifenacin Hydrobromide | 15 | $179.79▼ below NY avg | ≈ Typical |
About Darifenacin Er: Darifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, darifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. In 2023, this provider wrote 15 Medicare prescriptions for Darifenacin Er, about 75% of the volume of the typical New York prescriber of this medication (20). Medicare paid an average of $179.79 per fill, versus $206.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $128.90▼ below NY avg | ≈ Typical |
About Fesoterodine Fumarate Er: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). By relaxing the muscles in the bladder, fesoterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. In 2023, this provider wrote 13 Medicare prescriptions for Fesoterodine Fumarate Er, about 81% of the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $128.90 per fill, versus $191.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| Solifenacin Succinate | 13 | $24.50▼ below NY avg | ▼ Less than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2023, this provider wrote 13 Medicare prescriptions for Solifenacin Succinate, about a third of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $24.50 per fill, versus $91.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Doxazosin Mesylate | 12 | $22.47 | ▼ Less than typical |
About Doxazosin Mesylate: Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily. Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Doxazosin belongs to a class of drugs known as alpha blockers. A prazosin-related compound that is a selective alpha-1-adrenergic blocker. In 2023, this provider wrote 12 Medicare prescriptions for Doxazosin Mesylate, about a third of the volume of the typical New York prescriber of this medication (29). Medicare paid an average of $22.47 per fill, versus $21.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Trospium Chloride ErTrospium Chloride | 12 | $100.03▼ below NY avg | ▼ Less than typical |
About Trospium Chloride Er: This medication is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, trospium improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. Trospium belongs to a class of drugs known as antispasmodics. It is also known as an antimuscarinic. In 2023, this provider wrote 12 Medicare prescriptions for Trospium Chloride Er, about a third of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $100.03 per fill, versus $210.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| ZytigaAbiraterone Acetate | 12 | $10,614.84 | ≈ Typical |
About Zytiga: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 12 Medicare prescriptions for Zytiga, about 80% of the volume of the typical New York prescriber of this medication (15). Medicare paid an average of $10,614.84 per fill, versus $9,574.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for CHRISTOPHER M PIECZONKA M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Urology prescribing approach at this Syracuse, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
